Nykredit A/S’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Nykredit A/S's DNTH Position: Q3 2026 in Review
Nykredit A/S sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 1,505 shares — an estimated $147K sold.
Nykredit A/S first reported a position in DNTH in Q2 2026 and held it in 1 quarter. The position peaked at $147K in Q2 2026. 274 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Nykredit A/S reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
- Nykredit A/S sold 1,505 Dianthus Therapeutics shares in Q3 2026, an estimated $147K.
- Nykredit A/S first reported a position in Dianthus Therapeutics in Q2 2026 and held it in 1 quarter.
- Nykredit A/S's Dianthus Therapeutics position peaked at $147K in Q2 2026.
- 274 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.